| TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) (NCT03959241) | Medical College of Wisconsin | 2019-06-25 |
| Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS (NCT02730299) | Gamida Cell ltd | 2016-12-16 |
| Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation (NCT02259348) | St. Jude Children's Research Hospital | 2014-10-01 |
| Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation (NCT02226861) | National Heart, Lung, and Blood Institute (NHLBI) | 2014-08-26 |
| A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs (NCT02200380) | Celldex Therapeutics | 2014-07-01 |
| Phase I Study of Milatuzumab for Graft Versus Host Disease (NCT01663766) | Gilead Sciences | 2013-12-01 |
| IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT (NCT01885897) | Masonic Cancer Center, University of Minnesota | 2013-11-11 |
| Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study (NCT01735955) | Novartis Pharmaceuticals | 2013-03-29 |
| Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (NCT01758042) | Massachusetts General Hospital | 2012-11-01 |
| Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies (NCT01413568) | Polyphor Ltd. | 2012-04-01 |
| A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) (NCT01351545) | Center for International Blood and Marrow Transplant Research | 2011-10-01 |
| Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation (NCT01243489) | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | 2010-10-01 |
| Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells (NCT01050764) | Everett Meyer | 2009-06-01 |
| Unrelated Umbilical Cord Blood (UBC)Transplantation (NCT01768845) | West Virginia University | 2009-02-03 |
| A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation (NCT00672152) | Michael Morse, MD | 2007-06-01 |
| Nilotinib, for Patients With CML-CP or CML-AP (NCT04518644) | Novartis Pharmaceuticals | |